Proteomics Market Top Companies Study - Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US).

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Proteomics Market Size, Share & Trends Analysis Report By Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma), Region, Market Outlook And Industry Analysis 2031"

The global proteomics market is estimated to reach over USD 110.25 billion by 2031, exhibiting a CAGR of 13.84% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1896

Proteomics is a scientific discipline focused on the identification of disease-related proteins and the analysis of their synthesis, function, and structure. This approach is essential for the diagnosis and identification of prognostic biomarkers for diseases such as cancer, viral infections, malaria, and tuberculosis. In the pharmaceutical industry, proteomics is leveraged to evaluate drug efficacy and toxicity. Key drivers of market growth include the rising incidence of target diseases, the increasing demand for personalized medicine, and advancements in diagnostic techniques for targeted therapies. Moreover, the global proteomics market is poised for significant expansion, fueled by technological innovations, increased research funding, higher healthcare expenditures, and growing demand for precision medicine. The rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, respiratory conditions, and chronic kidney disease, is expected to further drive the market's growth in the coming years.

List of Prominent Players in the Proteomics Market:
• Agilent Technologies, Inc.
• Biognosys Ag
• Biomax Informatics Ag
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Charles River Laboratories
• Creative Proteomics
• Danaher
• Eurofins Scientific
• Fios Genomics
• Genewiz
• Horiba Corporation
• Illumina, Inc.
• Macrogen Inc.
• Medgenome Labs
• Merck Kgaa
• Perkinelmer, Inc.
• Promega Corporation
• Protagene Protein Services
• Qiagen N.V.
• Sengenics
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Wuxi Nextcode

Market Dynamics:
Drivers-
The proteomics market is experiencing robust growth, primarily driven by the increasing demand for personalized medicine, rising investments in research and development, enhanced government funding, and continuous technological innovations. As proteomics rapidly establishes itself as a vital field in disease diagnosis, several factors contribute to its expansion, including the broadening scope of R&D and the growing need for customized therapeutics. Major industry players are expected to intensify efforts to develop innovative and effective pharmaceutical products and diagnostic tools, further accelerating market growth over the forecast period. Additionally, advancements in cancer liquid biopsy research are driving the adoption of innovative methodologies and applications in the field. Strategic corporate initiatives are also expected to play a significant role in supporting the industry's growth in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Challenges:
The comparability of data in proteomics research is often limited by the absence of standardized methodologies, reference materials, and quality control measures across various platforms and laboratories, hindering the overall advancement of the field. Overcoming these challenges and ensuring the effective integration of proteomics in applications such as personalized medicine and drug discovery will require collaborative efforts from researchers, technology developers, regulatory bodies, and funding organizations. Furthermore, the validation of biomarkers identified through proteomics research presents a significant obstacle. The validation process necessitates large-scale clinical trials and the involvement of multiple stakeholders, making it both time-consuming and costly.

Regional Trends:
The North American proteomics market is expected to capture a substantial market share, fueled by extensive research into next-generation pharmaceuticals and the continuous growth of the field. Numerous protein-based therapies are currently being evaluated in clinical trials for the treatment of cancer, immune system disorders, infections, age-related diseases, and other health conditions, with the United States remaining at the forefront of proteomics research. Likewise, Europe holds a significant share of the market, driven by strong government funding and an increasing number of cancer research initiatives. The region's high concentration of manufacturers specializing in tailored therapeutics, alongside the rising incidence of cancer and other related diseases, further propels market growth.

Recent Developments:
• In June 2021, Bruker Corp. introduced the two new times TOF instruments. It makes new techniques and applications possible, including unbiased and in-depth multi-omics biomarker identification and epi proteomics/PTM characterization.
• In May 2020 saw the adoption of the MS approach by researchers from the University of Surrey to hasten and support the development of the COVID-19 vaccine. Microarray usage is expected to rise across various applications, supporting industry expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1896

Segmentation of Proteomics Market-
By Product-
• Spectroscopy
o Mass Spectrometry
o NMR Spectroscopy
o CD Spectroscopy
• Chromatography
o HPLC Chromatography
o Ion Chromatography
o Affinity Chromatography
o Superficial Chromatography
• Electrophoresis
o Gel Electrophoresis
o Capillary Electrophoresis
• Protein Microarrays
o Biochips
o Microarray Instruments
• X-Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
• Other Technologies
By Regents
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents
• Other Reagents (Edman's reagent, enzymes, cross-linking agents)
By Software & Services
• Core Proteomics Services
• Bioinformatics Software & Services
By Application-
• Clinical Diagnostic
• Drug Discovery & Development
• Others
By End users
• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic Research Laboratories
• Other End Users
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/proteomics-market-/1896

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.